Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Spanos

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The Laryngoscope|October 24, 2020
Prognostic Impact of Metastatic Site and Pattern in Patients with Metastatic Head and Neck CancerCraig A Bollig, Christopher I Newberry, Tabitha L I Galloway, et al.
Cancer Gene Therapy|August 25, 2012
A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumorsB G Wieking, D W Vermeer, W C Spanos, et al.
Oncogene|August 17, 2019
CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8<sup>+</sup> T-cell responses by upregulating MHC-I expressionJoseph A Westrich, Daniel W Vermeer, Alexa Silva, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 22, 2018
Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell CarcinomaJeffery B Jorgensen, Russell B Smith, Andrew Coughlin, et al.
Medical Oncology (Northwood, London, England)|March 8, 2021
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trialPeter Oppelt, Jessica Ley, Mackenzie Daly, et al.
Journal for Immunotherapy of Cancer|August 15, 2019
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibitionJared M Newton, Aurelie Hanoteau, Hsuan-Chen Liu, et al.
Nature Communications|October 18, 2018
Cancer exosomes induce tumor innervationMarianna Madeo, Paul L Colbert, Daniel W Vermeer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2026
The membrane-associated ubiquitin ligase MARCHF8 degrades MHC-I in HPV-positive head and neck cancer for immune evasionMohamed I Khalil, Jie Wang, Lexi Vu, et al.
The European Physical Journal. C, Particles and Fields|July 2, 2019
Likelihood analysis of the pMSSM11 in light of LHC 13-TeV dataE Bagnaschi, K Sakurai, M Borsato, et al.
Head & Neck|January 8, 2021
Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancerAshley C Mays, Bharat Yarlagadda, Virginie Achim, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Laryngoscope|October 24, 2020
Prognostic Impact of Metastatic Site and Pattern in Patients with Metastatic Head and Neck CancerCraig A Bollig, Christopher I Newberry, Tabitha L I Galloway, et al.
Cancer Gene Therapy|August 25, 2012
A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumorsB G Wieking, D W Vermeer, W C Spanos, et al.
Oncogene|August 17, 2019
CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8<sup>+</sup> T-cell responses by upregulating MHC-I expressionJoseph A Westrich, Daniel W Vermeer, Alexa Silva, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 22, 2018
Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell CarcinomaJeffery B Jorgensen, Russell B Smith, Andrew Coughlin, et al.
Medical Oncology (Northwood, London, England)|March 8, 2021
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trialPeter Oppelt, Jessica Ley, Mackenzie Daly, et al.
Journal for Immunotherapy of Cancer|August 15, 2019
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibitionJared M Newton, Aurelie Hanoteau, Hsuan-Chen Liu, et al.
Nature Communications|October 18, 2018
Cancer exosomes induce tumor innervationMarianna Madeo, Paul L Colbert, Daniel W Vermeer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2026
The membrane-associated ubiquitin ligase MARCHF8 degrades MHC-I in HPV-positive head and neck cancer for immune evasionMohamed I Khalil, Jie Wang, Lexi Vu, et al.
The European Physical Journal. C, Particles and Fields|July 2, 2019
Likelihood analysis of the pMSSM11 in light of LHC 13-TeV dataE Bagnaschi, K Sakurai, M Borsato, et al.
Head & Neck|January 8, 2021
Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancerAshley C Mays, Bharat Yarlagadda, Virginie Achim, et al.
Pageof 6